CAS: 81424-67-1 - Caracemide
Formula:C6H11N3O4
InChI:InChI=1S/C6H11N3O4/c1-4(10)9(5(11)7-2)13-6(12)8-3/h1-3H3,(H,7,11)(H,8,12)
InChI key:InChIKey=JURAJLFHWXNPHG-UHFFFAOYSA-N
SMILES:O=C(ON(C(=O)NC)C(=O)C)NC
- Synonyms:
- (Acetyl-(methylcarbamoyl)amino) N-methylcarbamate
- Acetamide, N-((methylamino)carbonyl)-N-((methylamino)carbonyl)oxy)-
- Brn 5935912
- Caracemida
- Caracemida [Spanish]
- Caracemide [USAN:INN]
- Caracemidum
- Caracemidum [Latin]
- Ccris 1729
- N-((Methylamino)carbonyl)-N-(((methylamino)carbonyl)oxy)acetamide
- See more synonyms
- N-(Methylcarbamoyl)-N-(methylcarbamoyloxy)acetamid
- N-(methylcarbamoyl)-N-[(methylcarbamoyl)oxy]acetamide
- N-Acetyl-N,O-bis(methylcarbamoyl)hydroxylamine
- N-Acetyl-N,O-di(methylcarbamoyl)hydroxylamine
- N-Acetyl-N-(methylcarbamoyloxy)-N'-methylurea
- Nsc 253272
- Unii-H74F6J185A
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-(Methylcarbamoyl)acetamido N-methylcarbamate REF: 3D-GDA42467CAS: 81424-67-1 | Min. 95% | To inquire | Tue 07 Jan 25 | |
Caracemide REF: TM-T14864CAS: 81424-67-1 | 98.81% | To inquire | Tue 14 Jan 25 |
N-(Methylcarbamoyl)acetamido N-methylcarbamate
CAS:81424-67-1
N-(Methylcarbamoyl)acetamido N-methylcarbamate (NMCA) is a novel anti-cancer compound that selectively binds to the CB2 receptor. …
Formula:
C6H11N3O4
Purity:
Min. 95%
Molecular weight:
189.17 g/mol
Ref: 3D-GDA42467
25mg | 359.00 € | ||
250mg | 1,435.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Caracemide
CAS:81424-67-1
Caracemide (NSC-253272) inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in …
Formula:
C6H11N3O4
Purity:
98.81%
Color and Shape:
Solid
Molecular weight:
189.17
- Inhibitors
- Reductase
- Microbiology/Virology
- DNA/RNA Synthesis
- See more categories
- Other Inhibitors
Ref: TM-T14864
1mg | 35.00 € | ||
2mg | 46.00 € | ||
5mg | 68.00 € | ||
10mg | 95.00 € | ||
25mg | 143.00 € | ||
50mg | 205.00 € | ||
100mg | To inquire | ||
1mL*10mM (DMSO) | 74.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025